This book provides a comprehensive, state-of-the art review of HBV infection and liver disease. It discusses new data on basic and translational medicine, including the viral life cycle, the immunopathogenesis of virus-induced chronic hepatitis, viral and host genetic factors affecting disease progression, and the mechanism of virus-induced hepatocarcinogenesis, as well as their potential applications in daily clinical practice. The clinical aspects of chronic HBV infection are examined in chapters on the global epidemiology, efficacy of HBV vaccination, natural history, novel biomarkers, co-infections with HCV, HDV or HIV, and management of special populations including children, pregnant women and patients undergoing immunosuppressive therapy. Further, it describes the advances and perspectives in the development of novel antiviral treatments for possible functional cure of HBV infection.
In this second edition, authors provides recent updates in epidemiology,biomarkers, antivirus therapy, and novel therapy for functional cure of chronic hepatitis B virus infection.
The book is a valuable resource for medical students, physicians, and researchers who are interested in management of patients with chronic HBV infection and investigation HBV infection.
Jia-Horng Kao
Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
